Dr. Scott K. Winiecki from the FDA’s Center for Drug Evaluation and Research Safe Use Team will present on “Opioids: Current and Future Directions for Addressing the Crisis.” He will discuss how the current situation evolved and focus on actions taken by the FDA to address the issues of opioid use, misuse, and abuse. In addition, he will review interventions from other sources, including academic researchers, state Prescription Drug Monitoring Programs, and other Federal Agencies. Specific approaches to be discussed will include the role of abuse deterrent formulations, the use of prescriber feedback, and the wider distribution of naloxone. Finally, Dr. Winiecki will touch upon possible directions and interventions that may be employed in the future.
Event Time: 10:00 AM
Dr. Scott K. Winiecki, MD
Team Lead, Safe Use Initiative
Professional Affairs and Stakeholder Engagement Staff
Center for Drug Evaluation and Research
US Food and Drug Administration
In this Webinar You Will Learn:
– Scope of the current situation
– FDA’s Role
– Addressing Opioid Issues and the Action Plan
– Solutions from Various Sources – Prescribers, States, Federal Agencies
– Future Direction
And Much More…..
About the Presenter:
Dr. Scott Winiecki received his MD from the University of Maryland School of Medicine and completed his pediatric training at the Children’s Hospital of Philadelphia. After 12 years in private pediatric practice, he joined FDA in 2011. In 2012, he received the FDA’s “Outstanding New Reviewer” award for his work on thromboembolism following immune globulin products. In 2014, he received a Public Health Achievement Award for leading the first project at FDA to use Sentinel electronic data combined with medical record review to rapidly refine a safety concern. In September, 2016, he joined the Safe Use Initiative at FDA, continuing his work in promoting patient safety and reducing preventable harm.
This Webcast Will Be of Interest To: